Is reduced E-cadherin expression a predictor of lower overall survival and metastatic disease in invasive ductal breast cancer?
We conclude that determination of E-cadherin expression can be used as an adjunct in selecting patients who may benefit from adjuvant chemotherapy in the presence of otherwise favorable prognostic factors.
Use of supplements improved the intake of folate, iron and vitamin D, but not sufficiently to reach the recommended amounts.